Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

3.200 USD +0.040 (+1.27%)
Official Closing Price Updated: 7:39 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Agenus Inc

< Previous 1 2
...
24 25 26 27 28 29 30 31 Next >
Agenus' HerpV Phase 2 Study to Treat Genital Herpes Completes Enrollment
From GlobeNewswire News Releases
Agenus to Present at Cowen and Company Annual Healthcare Conference
From GlobeNewswire News Releases
Agenus to Report Fourth Quarter and Year End 2012 Financial Results on February 28, 2013; Conference Call to Follow
From GlobeNewswire News Releases
Mentor Capital Cancer Immunotherapy Index Posts 11% Annual Loss in 2012 and Adds Companies for 2013
From Business Wire News Releases
Agenus to Present at BIO CEO & Investor Conference
From GlobeNewswire News Releases
Agenus to Present at OneMedForum San Francisco 2013
From GlobeNewswire News Releases
The Real Story Behind PGNX, OSUR, NVGN and AGEN
From Marketwired News Releases
Agenus to Present at Windhover's Therapeutic Area Partnerships Conference
From GlobeNewswire News Releases
Agenus (AGEN) up on drug trials
Normal 0 false false false MicrosoftInternetExplorer4 Agenus Inc. (NASDAQ: AGEN) shares rose 2.1% to $4.34, after some positive news from a drug trial. Share volume was 8,205. /* Style Definitions */... 
From Baystreet.ca RSS Feed
Efficacy Shown With GlaxoSmithKline's Phase 3 Malaria Vaccine Candidate, Which Contains Agenus' Qs-21 Stimulon(R) ADJUVANT
From GlobeNewswire News Releases
Agenus Reports Third Quarter 2012 Financial Results
Agenus to Host Conference Call Beginning at 11 a.m. ET Today 
From GlobeNewswire News Releases
Agenus Commences Phase 2 Study of HerpV Vaccine for the Treatment of Genital Herpes
From GlobeNewswire News Releases
Agenus to Report 3rd Quarter Financial Results on October 25, 2012; Conference Call to Follow
From GlobeNewswire News Releases
Aeras Signs Agreement with GSK to Jointly Advance TB Vaccine
From PR Newswire
Agenus to Present at 3rd Annual Cancer Immunotherapy Conference
From GlobeNewswire News Releases
Agenus to Present at the NewsMakers in the Biotech Industry Conference and the Rodman & Renshaw Global Investment Conference
From GlobeNewswire News Releases
Agenus Announces Publication of Key Data Showing Antitumor Activity of Prophage Vaccine (HSPPC-96) in Clinical Cancer Research
Large, Randomized Phase 2 Trial of Prophage G-200 With Avastin(R) in Recurrent Glioblastoma Patients to be Conducted by NCI Cooperative Group 
From GlobeNewswire News Releases
Agenus Reports Second Quarter 2012 Financial Results
Agenus to Host Conference Call Beginning at 11 am ET Today 
From GlobeNewswire News Releases
Agenus to Report 2nd Quarter Financial Results on August 2, 2012; Conference Call to Follow
From GlobeNewswire News Releases
Agenus Inc Enters Oversold Territory (AGEN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Mentor Capital Cancer Immunotherapy Index Gains 29% During First Half of 2012
From Business Wire News Releases
Uptrend Call Working As Antigenics Stock Rises 87.6% (AGEN)
From Comtex SmarTrend® News Briefs
Phase 3 Clinical Trial of GSK's Herpes Zoster Vaccine Candidate Containing Agenus' QS-21 Commences in Immunocompromised Patients
From GlobeNewswire News Releases
Uptrend Call Working As Antigenics Stock Rises 89.2% (AGEN)
From Comtex SmarTrend® News Briefs
Uptrend Call Working As Antigenics Stock Rises 91.0% (AGEN)
From Comtex SmarTrend® News Briefs
Agenus to Join Russell 3000 Index, Global Index, and MicroCap Index
From GlobeNewswire News Releases
Uptrend Call Working As Antigenics Stock Rises 95.9% (AGEN)
From Comtex SmarTrend® News Briefs
Agenus to Webcast 2012 Annual Shareholders Meeting
From GlobeNewswire News Releases
Uptrend Call Working As Antigenics Stock Rises 94.8% (AGEN)
From Comtex SmarTrend® News Briefs
Antigenics Earnings Hindsight: Down 8.9% in Last 19 Days (AGEN)
From Comtex SmarTrend® News Briefs
< Previous 1 2
...
24 25 26 27 28 29 30 31 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.